The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema
Authors
Keywords
-
Journal
BRITISH JOURNAL OF OPHTHALMOLOGY
Volume 101, Issue 1, Pages 75-80
Publisher
BMJ
Online
2016-12-14
DOI
10.1136/bjophthalmol-2016-309313
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting
- (2016) Namritha V. Patrao et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The Impact of Systemic Factors on Clinical Response to Ranibizumab for Diabetic Macular Edema
- (2016) Rishi P. Singh et al. OPHTHALMOLOGY
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intravitreal Ranibizumab on Retinal Hard Exudate in Diabetic Macular Edema
- (2015) Amitha Domalpally et al. OPHTHALMOLOGY
- Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema
- (2015) Alok S. Bansal et al. OPHTHALMOLOGY
- Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy
- (2015) David S. Boyer et al. OPHTHALMOLOGY
- Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment
- (2015) Ian Pearce et al. OPHTHALMOLOGY
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results
- (2015) Michael J. Elman et al. OPHTHALMOLOGY
- Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study)
- (2015) Ugo Menchini et al. Journal of Ophthalmology
- Vision-Related Function after Ranibizumab Treatment for Diabetic Macular Edema
- (2014) Neil M. Bressler et al. OPHTHALMOLOGY
- The Neovascular Age-Related Macular Degeneration Database
- (2014) Javier Zarranz-Ventura et al. OPHTHALMOLOGY
- Cost of hospital prescribing rose 15% in a year owing to new rheumatoid arthritis and cancer drugs
- (2014) N. Hawkes BMJ-British Medical Journal
- Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
- (2013) David M. Brown et al. OPHTHALMOLOGY
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment
- (2012) Michael J. Elman et al. OPHTHALMOLOGY
- Trends over time and geographical variation in rates of intravitreal injections in England
- (2011) Tiarnan D L Keenan et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2011) Michael J. Elman et al. OPHTHALMOLOGY
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
- (2010) Michael J. Elman et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation